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Abstract
Background: The interpretation of the SF-36 in Norwegian populations largely uses normative data from 1996. This
study presents data for the general population from 2002–2003 which has been used for comparative purposes but
has not been assessed for measurement properties.
Methods: As part of the Norwegian Level of Living Survey 2002–2003, a postal survey was conducted comprising
9,164 members of the general population aged 16 years and over representative for Norway who received the
Norwegian SF-36 version 1.2. The SF-36 was assessed against widely applied criteria including data completeness
and assumptions relating to the construction and scoring of multi-item scales. Normative data are given for the
eight SF-36 scales and the two summary scales (PCS, MCS) for eight age groups and gender.
Results: There were 5,396 (58.9%) respondents. Item levels of missing data ranged from 0.6 to 3.0% with scale scores
computable for 97.5 to 99.8% of respondents. All item-total correlations were above 0.4 and were of a similar level with
the exceptions of the easiest and most difficult physical function items and two general health items. Cronbach’s alpha
exceeded 0.8 for all scales. Under 5% of respondents scored at the floor for five scales. Role-physical had the highest
floor effect (14.6%) and together with role-emotional had the highest ceiling effects (66.3-76.8%). With three exceptions
for the eight age groups, females had lower scores than males across the eight health scales. The two youngest age
groups (<30 years) had the highest scores for physical aspects of health; physical function, role-physical, bodily pain
and general health. The age groups 40–49 and 60–69 years had the highest scores for role-emotional and mental
health respectively.
Conclusions: This SF-36 data meet necessary criteria for applications of normative data. The data is more recent, has
more respondents including older people than the original Norwegian normative data from 1996, and can help the
interpretation of SF-36 scores in applications that include clinical and health services research.
Background
The Short Form 36 (SF-36) Health Survey is the most
evaluated health status instrument and the most reported
within randomized controlled trials [1, 2]. The instrument
has been translated into many languages and the results of
these studies are published in peer-reviewed journals [3].
SF-36 Version 1 [4] and the RAND-36 [5] include the
same items and continue to be widely used, including in
the great majority of Norwegian studies that include this
instrument. The SF-36 is available in self- or interview-
administered formats and standard (four weeks) and acute
(one week) recall periods.
The SF-36 was developed as part of the Medical Out-
comes Study (MOS), a key objective of which was to de-
velop more practical tools for monitoring the outcomes of
medical care [4, 6, 7]. The instrument includes 36 items or
questions that assess functional health and well-being
from the perspective of the patient. The items contribute
to eight health domains of physical functioning, role limi-
tations due to physical problems, bodily pain, general
health, vitality, social functioning, role limitations due to
emotional problems and mental health. The eight do-
mains all contribute to physical component summary
(PCS) and mental component summary (MCS) scores,
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with their relative weights based on the results of factor
analysis [8]. Short-forms include the SF-12 [9] and SF-8
[10] which give summary scores along with single item
scores for each domain in the case of the latter.
Normative data derived from surveys of representative
samples of the general population aid the interpretation
of the SF-36 scale and summary scores [11]. Normative
data has been available following early evaluations of the
instrument, for example as part of the International
Quality of Life Assessment (IQOLA) Project [3, 12].
Much of this data was collected in the 1990s following
forward backward translations and testing for cross-
cultural equivalence [3, 13, 14]. These normative data
continue to be used [15–17] but more recent data is
available for countries that were not included in the
IQOLA Project [18–20].
The Norwegian SF-36 version 1.1 was forward back-
wards translated according to the IQOLA procedures
and evaluated in patients with rheumatoid arthritis re-
cruited from a patient register for Oslo [21]. Problems
with missing data and suboptimal psychometric charac-
teristics led to slight revisions to five items in version 1.2
[12], the one commonly used in Norway. This version
was evaluated in a nationally representative sample of
the Norwegian general population in the spring of 1996
and was used to derive the Norwegian norms [12]. The
data is over 20 years old and may no longer be represen-
tative of the general population due to changes in both
the composition of the general population and how indi-
viduals respond to such questions.
The present study presents more recent normative
data for the Norwegian SF-36 v1.2 [22]. This data has
been used to help the interpretation of SF-36 scores in
Norwegian studies since 2013 [23–25]. Compared to the
original Norwegian norms [12], there are a larger num-
ber of respondents including older people, which further
contributes to the appropriateness of this new normative
data. However, the measurement properties of this nor-
mative data have not been reported. Norms are also
given for the SF-36 summary scales, which were devel-
oped later and hence were not included in the original
normative data. The study also presents norms for the
two scales that have a different scoring algorithm ac-
cording to the RAND scoring together with alternative
scoring for the summary scales [26–28]. The present
study follows the IQOLA project and existing studies
that have evaluated the SF-36 in general populations in-
cluding tests of data quality and internal consistency.
Methods
Data collection
The postal survey comprised 9,164 members of the gen-
eral population aged 16 years and over that were repre-
sentative for Norway (Fig. 1). It was conducted as part of
the Norwegian “Level of Living Survey 2002” cross sec-
tional study on health undertaken by Statistics Norway
and included home and telephone interviews prior to
the postal survey [22]. The postal questionnaire included
the Norwegian SF-36 version 1.2 mailed in the period 15
November 2002 to 15 May 2003. SF-36 data were avail-
able for the 5,396 interview participants only from the
Norwegian Social Science Data Services AS (NSD).
Measurement properties
The analysis followed the measurement criteria evalu-
ated as part of the IQOLA project that included the
Norwegian version of the SF-36 [3]. Data completeness
was evaluated by considering the percentage of respon-
dents with missing data at the item and scale levels in-
cluding the percentage of scale scores calculable
according to the SF-36 scoring. According to classical
test theory and the construction of summated rating
scales, item means are expected to be roughly equal but
this is seldom the case due to heterogeneity of item con-
tent. For the physical functioning scale it was hypothe-
sized that items assessing the least strenuous activities
would have the highest mean scores and that the climb-
ing stairs and walking items would have item means or-
dered as a Guttman scale. For the two role functioning
scales it was hypothesized that the items relating to “ac-
complished less than you would like” would have the
lowest item means. For the vitality scale it was hypothe-
sized that vitality items assessing well-being would have
lower mean scores than items assessing disability, since
the former define higher levels of health. For the mental
health scale it was hypothesized that items assessing
positive affect would have lower item means than those
assessing negative affect. Internal consistency was
assessed by item-total correlation and Cronbach’s alpha.
Item-total correlations of 0.4 or higher were considered
satisfactory and should be approximately equal within
each scale [3]. Definite scaling success was defined as an
item correlating by two standard errors or more with its
scale than with another scale and probable scaling suc-
cess when the correlation was higher but not by two
standard errors [3]. Cronbach’s alpha should be at least
0.70 and 0.90 for group and individual level analyses re-
spectively [3]. Floor and ceiling effects were assessed
through the percentage of respondents with the lowest
and highest scale scores.
Normative data
Normative data are presented in the same manner as
previous SF-36 studies and are broken down by age and
gender [12, 14]. For the PCS and MCS, normative data
are given for the standard scoring derived using an un-
correlated (orthogonal) factor solution [8] and scoring
based on a correlated (oblique) factor solution [26]. The
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former is based on data for the general population of the
US standardized to have a mean of 50 and standard de-
viation of 10 [8]. The latter uses weights derived from an
oblique factor solution [26] standardized to have a mean
of 50 and standard deviation of 10 in the current sample.
The RAND scoring of the SF-36 is an alternative scoring
for the same questionnaire (here Norwegian version 1.2).
It has slightly different scoring for the bodily pain and
general health scales. This study gives normative data
for these scales alongside the alternative scoring for the
PCS and MCS.
IBM SPSS 23 was used for descriptive statistics and to
assess the measurement properties.
Results
Data collection
Of 9,675 eligible members of the general population, 511
people did not receive a questionnaire because of dis-
ability, language difficulties, or they refused. Of the
9,164 who received a questionnaire, SF-36 data were
available for the 5,396 (55.8%) respondents who had also
participated in the interviews (Fig. 1) and their back-
ground characteristics are shown in Table 1 [22].
Measurement properties
Table 2 shows that the item levels of missing data ranged
from 0.6 to 3.0% for the bodily pain item “how much did
pain interfere with your normal work” and general
health item “I seem to get sick easier than others” re-
spectively. Levels of complete data for the eight scales
ranged from 95.4 to 98.6% for general health and social
functioning respectively. Following score computation
the level of missing data ranged from 0.2 to 2.5% for
these two scales. Levels of missing data were slightly
higher for the summary scales, which are dependent on
complete data for scale scores.
For the physical functioning scale, the easiest and most
difficult items had the highest and lowest means respect-
ively (Table 2). Item means increased with Guttman
scale ordering across the two sets of items relating to
Fig. 1 Data Collection
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climbing stairs and walking. The items “accomplished
less than you would like” had the lowest means for the
two role functioning scales. For vitality, the item “have a
lot of energy” had the lowest mean score. For mental
health the two items assessing positive affect had the
lowest mean scores. The mental health item assessing
the worst mental health state “so down in the dumps
that nothing could cheer you up” had the highest mean
score. The item score standard deviations were roughly
equivalent within scales with the exceptions of the easi-
est and most difficult physical functioning items and the
vitality and mental health scale items relating to positive
and negative aspects of health.
The item-total correlations all exceeded the 0.4 criter-
ion and in general were fairly similar in size with two ex-
ceptions including the easiest and most difficult physical
functioning items. The two general health items relating
to “I seem to get sick easier than others” and “I expect
my health to get worse” also had somewhat lower corre-
lations than the other items for this scale. With the ex-
ceptions of the physical functioning item relating to
vigorous activities which had two correlations indicative
of probable scaling success (within two standard errors)
with the role-physical and general health scale items,
there was 100% scaling success for all of the items.
Cronbach’s alpha exceeded 0.8 for all scales and the
physical functioning, role-physical and pain scales met
the criterion for individual level analysis.
Less than 5% of respondents scored at the floor for six
scales. The highest floor effect of 14.6% was for the role-
physical scale, which together with the role-emotional
scale also had the highest ceiling effects of 66.3 and
76.8% respectively. Ceiling effects were also high for the
social functioning scale and over 35% for the physical
functioning and bodily pain scales.
PCS and MCS were computable for 95.5% respondents
with mean scores of 49.5 (10.2) and 51.2 (9.1) for the
standard scoring.
Normative data
Tables 3 and 4 give the normative data by gender for the
different age groups. Table 3 is based on the standard
scoring for the PCS and MCS [8] and Table 4 is based
on the oblique (correlated) factor solution [26] and also
includes the RAND scoring for bodily pain and general
health. Across the age groups, females had lower scores
than males, the only exceptions being small differences
for physical functioning for 15–19 years, bodily pain for
20–29 years and general health for those over 79 years.
Most of the differences were within two scale points up
to the age group 50–59 years. However, females had
lower scores of up to seven scale points for role-
emotional in the age range 15–19 years. Much smaller
differences were found for the remaining groups up to
50–59 years, where females scored two or more points
lower for all scales with the exception above. For this
and the older groups, the differences between the two
genders generally increased for physical function, role-
physical, bodily pain and social function with the largest
differences for the oldest age group being for physical
functioning at over 14 points. The difference for the
remaining scales decreased for the two oldest age
groups. The two youngest age groups had the highest
scores for physical aspects of health; physical function,
role-physical, bodily pain and general health. The age
groups 40–49 and 60–69 years had the highest scores
for role-emotional and mental health respectively.
Across the age groups females had lower PCS and
MCS scores, the only exception being for MCS in the
age group over 79 years with the standard scoring
(Table 3). The younger age groups had the highest PCS
scores, which declined with successive age groups. For
the standard scoring the MCS scores increased with suc-
cessive age groups until the age group 60–69 and de-
clined in the two older age groups. For the alternative
scoring, MCS scores were very similar across the age
groups above 15–19 years and there was a slightly
Table 1 Characteristics of respondents (n = 5396)
Number Percent
Age, years; mean (SD) 46.57 (17.44)


















Under 10 yrs 839 16.49
10 – 12 yrs 2746 53.97
University (>12 yrs) 1503 29.54
aMissing data for one respondent
bMissing data for 141 respondents
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Physical functioning 0.87 95.37 86.44 20.42 0.45 35.60 0.92 97.50
1 Vigorous activites 1.54 2.16 0.76 22.55 38.15 0.55 75
2 Moderate activities 1.26 2.71 0.56 5.61 76.71 0.83 100
3 Lifting or carrying groceries 1.46 2.79 0.50 4.29 83.49 0.76 100
4 Climbing several flights of stairs 1.15 2.71 0.58 6.22 76.90 0.80 100
5 Climbing one flight of stairs 1.61 2.87 0.40 2.41 89.83 0.75 100
6 Bending, kneeling, stooping 1.17 2.69 0.59 6.43 75.51 0.74 100
7 Walk more than a mile 1.35 2.70 0.61 7.95 77.46 0.79 100
8 Walking several blocks 1.70 2.87 0.42 3.15 89.69 0.78 100
9 Walking one block 1.98 2.91 0.34 1.85 92.93 0.70 100
10 Bathing or dressing 0.89 2.91 0.34 1.66 92.89 0.61 100
Role-physical 0.85 97.59 76.64 37.39 14.62 66.32 0.91 100
1 Cut down time spent on work 1.15 1.81 0.40 19.35 80.65 0.78 100
2 Accomplished less than would like 1.02 1.72 0.45 27.61 72.39 0.76 100
3 Limited in kid of work/activities 1.76 1.77 0.42 23.30 76.70 0.80 100
4 Difficulty performing work/activities 0.95 1.77 0.42 22.60 77.40 0.83 100
Bodily paina 0.26 97.70 73.62 25.83 0.63 35.56 0.90 100
1 Intensity of bodily pain 1.98 4.67 1.40 1.91 36.66 0.82 100
2 Extent pain interfered with work 0.57 4.69 1.31 2.05 35.58 0.82 100
General healtha 2.52 95.89 75.25 21.72 0.23 8.21 0.82 100
1 Rating of general health 0.61 3.68 1.04 3.56 12.40 0.68 100
2 I seem to get sick easier than others 3.04 4.44 1.03 2.01 73.13 0.51 100
3 I seem as healthy as anyone I know 2.19 4.26 1.10 3.58 59.44 0.63 100
4 I expect my health to get worse 2.59 3.74 1.26 4.85 42.69 0.52 100
5 My health is excellent 2.46 3.92 1.31 6.56 39.83 0.76 100
Vitality 1.22 95.79 60.72 20.61 0.73 2.40 0.85 100
1 Full of pep 2.46 3.62 1.31 6.75 6.38 0.64 100
2 Have a lot of energy 2.26 3.55 1.36 8.57 6.12 0.75 100
3 Feel worn out 1.85 4.52 1.15 2.59 16.11 0.68 100
4 Feel tired 1.30 4.45 1.13 2.22 13.31 0.70 100
Social Functioning 0.17 98.85 86.27 21.18 0.84 58.40 0.81 100
1 Extent health problems interfered 0.61 4.51 0.87 1.55 68.73 0.69 100
2 Frequency health problems interfered 0.70 4.40 0.95 2.11 63.55 0.69 100
Role-Emotional 1.58 97.72 84.23 31.67 8.53 76.84 0.84 100
1 Cut down time spent on work 1.41 1.87 0.34 12.93 87.07 0.71 100
2 Accomplished less than would like 1.46 1.80 0.40 20.50 79.50 0.74 100
3 Work not done as carefully as usual 1.65 1.86 0.35 13.96 86.04 0.68 100
Mental Health 1.57 95.53 80.27 15.47 0.13 6.93 0.82 100
1 Been a very nervous person 1.98 5.60 0.80 0.55 72.75 0.60 100
2 Feel down in the dumps 2.11 5.75 0.70 0.40 84.13 0.62 100
3 Felt calm and peaceful 2.02 4.36 1.34 3.67 20.65 0.65 100
4 Felt downhearted and blue 2.37 5.30 0.95 0.87 51.90 0.68 100
5 Been a happy person 1.74 4.07 1.19 2.24 9.64 0.61 100
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sharper decline in scores for two oldest age groups com-
pared to that for the standard scoring (5 versus 2.6
points).
Discussion
This study was based on a general population survey
from 2002–2003 [22] and provides more recent norma-
tive data for the Norwegian SF-36 version 1.2. This ver-
sion of the SF-36 continues to be by far the most widely
used in Norway together with normative data from
1996. The composition of the Norwegian general popu-
lation has changed within this time, and the way individ-
uals interpret and respond to items within health
surveys also may have changed. Three Norwegian stud-
ies have used this more recent general population data
for normative comparisons [23–25]. The current study
is the first to assess this data for necessary measurement
properties that have been widely applied in studies relat-
ing to normative data for the SF-36 including the
IQOLA project [3].
The results of these analyses are an important pre-
requisite to publishing new normative data and using it
for score interpretation. They show that the SF-36 has
data completeness and that the instrument meets the
criteria underlying the construction and scoring of
multi-item scales [3]. Levels of missing data were low
and scaling assumptions were met in this population.
With the exception of one item relating to bodily pain,
items had lower levels of missing data than for those for
the Norwegian general population data collected as part
of the IQOLA project [12]. The Scandinavian countries
taking part in the IQOLA project had consistently
higher levels of missing data across the 36-items than
the other eight countries [3]. The present study found
rates of missing data that were more in line with those
for the other countries. All the correlations between the
items and hypothesized scales met the criterion of 0.4.
The levels of correlation were roughly equivalent with
the same exceptions as those found in the IQOLA pro-
ject [3]. Cronbach’s alpha was greater than the criterion
of 0.7 for group analyses and met the criterion of 0.9 for
individual analyses for three scales. The levels were com-
parable to those found for Norway in the IQOLA Pro-
ject with a slightly higher range of 0.81–0.92 compared
to 0.79–0.90 [3]. Item means within the scales were gen-
erally similar to the original Norwegian normative data
[3]. Compared to the earlier norms, item means were
slightly lower for physical functioning, role-physical,
general health and role-emotional scales. They were
slightly higher for vitality and mental health. The levels
of floor and ceiling effects were broadly comparable to
those found in the IQOLA project.
There are three possible reasons for the differences
with the original Norwegian normative data. First,
changes in the composition of the general population in
the intervening period including age composition and an
increased number of immigrants. Second, changes in the
way in which individuals respond to SF-36 items which
might follow increasing education and welfare levels.
Third, this is the same version of the SF-36 as that used
in the IQOLA project but subtle differences in the de-
sign and layout may have influenced responses. The
former used an early standard layout for the SF-36
whereas the present survey used a slightly different more
compact layout. It is only possible to speculate about the
role of these different factors but together they represent
good grounds for collecting and making available up-to-
date normative data for widely used generic instruments
including the SF-36.
Compared to the original normative Norwegian SF-36
data [12] this study has three important strengths. First,
there are 3,000 more respondents in the current study
compared to the original normative data, which makes
the data a more suitable basis for interpreting SF-36
scores and changes in those scores for respondents with
different health problems. Normative data has often a
lower proportion of older respondents and particularly
those aged 70 and over. Life expectancy continues to in-
crease and an increasing proportion of applications of
the SF-36 will include older people. The present study
included 619 respondents in this age range who com-
pleted at least one SF-36 scale compared to just 227 for
the original Norwegian normative data [12]. Moreover,
there were 181 respondents aged over 79 years in the
current study, which will improve the interpretation of
SF-36 scores for older people with health problems. Sec-
ond, during the two decades up to 2010, Norway has ex-
perienced better living standards coupled with changes
in the composition of the general population including
increasing numbers of immigrants, older people and in-
creasing numbers of people living alone. Such changes
will contribute to changes in the health status of the
Table 2 Descriptive statistics and internal consistency (n = 5396) (Continued)
Health Transition 0.46 99.54 51.26 16.53 1.62 3.91 - -
1 Change in health from one year ago 0.46 3.05 0.66 - - - -
Physical Component Summary 4.52 95.48 49.49 10.16 - - - -
Mental Component Summary 4.52 95.48 52.19 9.08 - - - -
aRAND mean (SD) scores for bodily pain 76.90 (24.94) and general health perception 73.84 (21.45)
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15–19 Male N 152 152 152 151 152 152 151 152 150 150
Mean 92.93 90.79 82.76 80.75 59.11 87.91 89.62 78.51 53.76 50.84
SD 16.14 22.23 19.94 18.22 19.78 19.05 25.59 14.86 6.32 8.62
Female N 142 143 144 144 144 144 144 144 141 141
Mean 93.30 88.23 79.34 77.74 52.95 84.81 81.71 74.23 53.49 47.69
SD 14.21 24.47 20.82 19.26 18.18 19.62 31.00 15.07 7.10 9.62
Total N 294 295 296 295 296 296 295 296 291 291
Mean 93.11 89.55 81.09 79.28 56.11 86.40 85.76 76.43 53.63 49.31
SD 15.21 23.34 20.41 18.76 19.24 19.36 28.58 15.09 6.70 9.24
20–29 Male N 325 325 327 323 327 327 325 327 321 321
Mean 95.90 88.31 80.88 81.31 61.34 89.49 88.21 79.08 53.76 51.07
SD 10.41 27.53 22.68 18.29 18.58 18.68 26.86 14.68 7.08 8.75
Female N 399 399 400 397 398 401 399 398 395 395
Mean 94.40 87.93 81.03 79.93 58.27 88.93 87.55 78.75 53.41 50.67
SD 11.44 27.28 22.07 17.78 18.02 17.26 27.22 13.85 7.07 8.87
Total N 724 724 727 720 725 728 724 725 716 716
Mean 95.07 88.10 80.97 80.54 59.65 89.18 87.85 78.90 53.57 50.85
SD 11.01 27.38 22.33 18.01 18.32 17.90 27.04 14.22 7.07 8.81
30–39 Male N 482 482 482 479 481 482 482 481 478 478
Mean 94.64 87.86 80.01 80.57 62.78 89.70 90.32 80.31 53.01 52.07
SD 10.71 27.65 22.88 18.22 19.38 17.88 25.58 14.01 7.46 8.49
Female N 533 533 534 530 534 534 530 534 525 525
Mean 92.47 82.83 77.28 79.82 58.36 87.29 86.98 79.00 52.04 51.02
SD 13.67 33.24 24.26 20.66 20.24 20.49 28.77 15.46 8.90 9.56
Total N 1015 1015 1016 1009 1015 1016 1012 1015 1003 1003
Mean 93.50 85.22 78.57 80.17 60.45 88.44 88.57 79.62 52.50 51.52
SD 12.40 30.80 23.64 19.54 19.95 19.33 27.34 14.80 8.25 9.08
40–49 Male N 546 547 548 543 547 549 543 545 536 536
Mean 91.74 84.23 76.58 79.11 64.29 88.41 90.36 81.12 51.53 52.96
SD 14.62 31.05 25.03 19.72 19.37 19.48 25.27 15.63 8.29 8.53
Female N 530 529 529 525 529 531 526 529 518 518
Mean 89.93 80.99 72.38 77.23 59.76 87.03 87.67 80.20 50.10 52.15
SD 16.11 34.42 25.60 21.65 20.65 20.74 28.41 15.56 9.81 9.56
Total N 1076 1076 1077 1068 1076 1080 1069 1074 1054 1054
Mean 90.85 82.64 74.52 78.19 62.06 87.73 89.04 80.67 50.82 52.56
SD 15.39 32.77 25.39 20.70 20.13 20.11 26.88 15.60 9.10 9.06
50–59 Male N 484 483 488 481 486 489 486 485 472 472
Mean 87.04 79.30 73.53 74.22 65.25 88.42 86.76 82.87 49.21 53.90
SD 18.64 36.13 25.92 22.01 19.87 18.76 29.42 14.56 9.80 8.15
Female N 490 488 489 486 487 490 484 488 475 475
Mean 82.38 71.11 66.36 70.81 58.30 83.06 84.33 80.44 46.40 52.59
SD 21.21 40.47 28.06 24.27 22.21 24.28 32.86 16.22 11.40 9.18
Total N 974 971 977 967 973 979 970 973 947 947
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general population and therefore there is a need for more
recent normative data. Third, the standard scoring for the
SF-36 summary scales has been criticized [5, 26–28]. The
current study includes normative data for both the PCS
and MCS summary scores and the alternative RAND scor-
ing for both these and the scales of bodily pain and general
health. This normative data has not previously been re-
ported for Norway. The alternative scoring algorithm is
based on a correlated (oblique) physical and mental health
factor model that is considered more appropriate given the
moderate level of correlation found between physical and
mental health [5, 26–28]. The authors of the alternative
scoring algorithm recommend that weights be derived
from other samples [26], which might include Norwegian
data together with a comparison of weights based on the
standard scoring. However, the use of the published US
weights, as in the present study, enables comparisons with
existing studies.
There are several possible study limitations. The main
weaknesses of the present study are that it was not spe-
cifically designed for collecting normative data and the
age of the data. Studies that are designed to collect nor-
mative data are costly and rarely undertaken. The study
was pragmatic in its use of the most recent general
population data available in Norway with a sufficient
sample size. This data was used for comparative pur-
poses in three recent Norwegian studies [23–25] which
may be seen as a response to the need for more up-to-
date normative data. It was therefore necessary to assess
data completeness and to test the assumptions under-
lying the eight multi-item scales which comprise the SF-
36 in this general population. The survey was part of a
larger survey [22], which included home or telephone in-
terviews with respondents prior to the postal survey de-
scribed here. It is possible that prior contact including
interviews may have influenced the response rate or
Table 3 Mean SF-36 scale and summary scores based on standard scoring [8] by gender and age groups (n = 5396) (Continued)
Mean 84.69 75.18 69.94 72.51 61.77 85.74 85.55 81.65 47.80 53.25
SD 20.10 38.57 27.24 23.23 21.35 21.85 31.19 15.46 10.72 8.70
60–69 Male N 335 336 340 328 334 339 329 333 316 316
Mean 83.10 70.66 70.63 71.33 66.77 88.09 86.02 83.63 46.71 54.96
SD 19.29 39.88 24.82 21.56 19.97 18.59 29.80 14.65 10.18 8.04
Female N 334 331 332 321 329 333 329 329 313 313
Mean 75.42 62.41 65.08 67.26 59.81 84.87 77.51 80.42 43.93 53.08
SD 23.16 42.41 26.69 23.64 21.72 21.90 35.41 16.04 11.86 9.38
Total N 669 667 672 649 663 672 658 662 629 629
Mean 79.26 66.57 67.89 69.32 63.32 86.50 81.76 82.03 46.32 54.03
SD 21.64 41.33 25.89 22.68 21.13 20.35 32.98 15.43 11.13 8.78
70–79 Male N 202 201 210 193 198 210 195 196 180 180
Mean 74.18 57.79 70.52 65.74 61.90 82.50 74.27 82.75 44.24 53.58
SD 24.28 42.92 25.50 22.28 23.57 25.10 37.16 16.70 10.17 8.87
Female N 224 226 228 208 219 227 219 214 195 195
Mean 63.28 46.61 61.84 63.29 56.69 77.09 60.27 78.53 40.84 51.10
SD 27.20 43.94 29.73 22.89 22.80 26.05 44.32 17.96 11.35 10.12
Total N 426 427 438 401 417 437 414 410 375 375
Mean 68.45 51.87 66.00 64.47 59.16 79.69 66.87 80.55 42.47 52.29
SD 26.40 43.77 28.09 22.60 23.29 25.71 41.65 17.48 10.92 9.61
80+ Male N 69 69 72 65 69 74 71 67 61 61
Mean 60.16 34.54 65.39 59.80 55.68 75.84 55.40 79.68 38.31 50.83
SD 27.31 41.35 25.30 23.91 22.76 28.39 42.89 17.61 10.47 10.13
Female N 102 106 107 86 96 105 98 89 76 76
Mean 45.84 23.35 53.50 60.34 52.36 68.21 53.40 77.59 35.99 51.84
SD 28.64 35.57 29.11 20.83 22.93 29.67 44.32 18.21 10.59 9.64
Total N 171 175 179 151 165 179 169 156 137 137
Mean 51.62 27.76 58.28 60.11 53.75 71.37 54.24 78.49 37.02 51.39
SD 28.90 38.23 28.18 22.13 22.85 29.31 43.61 17.93 10.56 9.83
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responses to the postal questionnaire but assessment of
such bias was not possible given the study design.
Conclusion
In conclusion, more recent data for the SF-36 version
one from a large scale survey of the Norwegian general
population met important criteria described in the
IQOLA Project [3]. The study found adequate evidence
to support the use of the data for normative compari-
sons in Norwegian studies. It is recommended that this
data is used in clinical and health services research for
normative comparisons until more up-to-date general
population data that are derived from a survey specific-
ally designed for this purpose are available for the SF-36
in Norway.
Table 4 Mean SF-36 scale and summary scores based on











15–19 Male N 152 151 150 150
Mean 86.07 79.39 53.36 49.77
SD 18.91 18.47 6.34 8.95
Female N 144 144 141 141
Mean 83.21 76.12 52.14 46.82
SD 19.38 19.23 6.44 9.04
Total N 296 295 291 291
Mean 84.68 77.79 52.77 48.34
SD 19.16 18.88 6.41 9.10
20–29 Male N 327 323 321 321
Mean 83.86 79.81 53.31 50.08
SD 21.08 18.44 6.49 8.78
Female N 400 397 395 395
Mean 84.24 78.30 52.92 49.69
SD 20.62 17.83 6.21 8.34
Total N 727 720 716 716
Mean 84.07 78.98 53.10 49.87
SD 20.81 18.11 6.34 8.53
30–39 Male N 482 479 478 478
Mean 83.04 79.10 53.04 50.74
SD 21.29 18.21 6.90 8.56
Female N 534 530 525 525
Mean 80.52 78.29 51.82 49.63
SD 23.22 20.54 8.15 9.43
Total N 1016 1009 1003 1003
Mean 81.72 78.68 52.40 50.16
SD 22.35 19.46 7.60 9.04
40–49 Male N 548 543 536 536
Mean 79.73 77.62 52.05 51.14
SD 23.89 19.57 7.90 9.37
Female N 529 525 518 518
Mean 75.93 75.73 50.64 50.10
SD 24.61 21.44 8.87 9.61
Total N 1077 1068 1054 1054
Mean 77.86 76.69 51.36 50.63
SD 24.31 20.52 8.41 9.50
50–59 Male N 488 481 472 472
Mean 76.79 72.84 50.36 51.60
SD 24.87 21.69 9.32 9.28
Female N 489 486 475 475
Mean 69.64 69.47 47.58 49.46
SD 27.78 23.81 10.85 10.15
Total N 977 967 947 947
Table 4 Mean SF-36 scale and summary scores based on
alternative scoring [26] by gender and age groups (n = 5396)
(Continued)
Mean 73.21 71.15 49.97 50.53
SD 26.60 22.83 10.21 9.78
60–69 Male N 340 328 316 316
Mean 74.21 70.00 48.50 51.73
SD 23.90 21.15 9.41 9.03
Female N 332 321 313 313
Mean 68.73 66.00 45.51 49.21
SD 26.25 23.06 10.82 10.02
Total N 672 649 629 629
Mean 71.50 68.02 47.01 50.48
SD 25.22 22.19 10.24 9.61
70–79 Male N 210 193 180 180
Mean 73.94 64.57 45.60 50.32
SD 24.74 21.74 10.50 10.50
Female N 228 208 195 195
Mean 64.85 62.25 41.77 47.07
SD 29.58 22.28 11.67 11.15
Total N 438 401 375 375
Mean 69.21 63.37 43.61 48.63
SD 27.71 22.02 11.27 10.95
80+ Male N 72 65 61 61
Mean 68.54 59.01 39.08 46.65
SD 25.20 23.42 10.86 11.34
Female N 107 86 76 76
Mean 56.12 59.25 37.59 45.76
SD 29.61 20.06 10.23 10.95
Total N 179 151 137 137
Mean 61.12 59.14 38.25 46.15
SD 28.51 21.49 10.50 11.09
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